Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis
Frontiers in Neuroendocrinology, 06/24/09
Kipp M et al. – A review of the impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis summarizes results of in vitro studies and experimental animal models and surveys the literature.
Methods- Review of sex steroids impact on neuroinflammatory processes and experimental multiple sclerosis
- Synthetic and natural estrogens as well as progestins modulate neuronal development and activity
- Steroids attenuate neuroinflammation by reducing pro-inflammatory property of astrocytes
- Variable effect based on brain region and toxic condition
- Both hormones can individually mediate protection, with more effective cooperation
- Animal model for multiple sclerosis shows steroids achieve remyelination after demyelination
- Cellular mechanisms involve interactions with astroglia, insulin-like growth factor-1 responses, and recruitment of oligodendrocytes
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
Archives of Neurology, 10/14/09
Changes in Hippocampal Metabolites After Effective Treatment for Fibromyalgia: A Case Study
The Clinical Journal of Pain, 10/20/09
Neurological symptoms in patients with biopsy proven celiac disease
Movement Disorders, 11/03/09
Today in Demyelinating Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial : The Lancet
The Lancet - Early Online Publication, 10/08/09
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
The Lancet Neurology, 10/16/09
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Medical treatment of Cushing's disease: Overview and recent findings
International Journal of General Medicine, 10/21/09
Predicting Recurrence of Nonfunctioning Pituitary Adenomas
Journal of Clinical Endocrinology and Metabolism, 10/15/09
The pituitary-adrenal axis in adult thalassaemic patients
European Journal of Endocrinology, 11/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


